Suppr超能文献

[2002 - 2019年河南省15岁及以上接受抗逆转录病毒治疗的HIV/AIDS病例死亡率分析]

[Analysis on mortality in HIV/AIDS cases aged 15 years and older under antiretroviral treatment in Henan province, 2002-2019].

作者信息

Yang W J, Liu Y, Li J, Ma Y M, Li N

机构信息

Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Sep 10;42(9):1594-1600. doi: 10.3760/cma.j.cn112338-20210308-00184.

Abstract

To analyze the mortality in HIV/AIDS cases aged ≥15 years under antiretroviral treatment (ART) in Henan province from 2002 to 2019, and provide evidence for reducing the mortality rate of HIV/AIDS and AIDS prevention and treatment. Data of HIV/AIDS cases aged ≥15 years who received ART in Henan from 2002 to 2019 were obtained from "Infectious Disease Surveillance System - Basic Information on AIDS Prevention and Control". In this retrospective study, Cox proportional risk model was used to analyze the influencing factors for HIV/AIDS related deaths. Software SPSS 23.0 was used for statistical analysis. From 2002 to 2019, a total of 72 986 HIV/AIDS cases aged ≥15 years received ART, in whom, 16 634 died during this period. Most of the death cases were aged ≥40 years old (68.5%,11 393/16 634), males (62.6%,10 419/16 634), infected through blood-borne transmission (71.7%,11 927/16 634), and farmers or migrant workers (91.7%,15 249/16 634). Most of the deaths were due to AIDS related diseases (73.7%, 12 261/16 634), and the case fatality rate was 16.8% (12 261/72 986). A total of 34.6% (4 237/12 261) of HIV/AIDS cases died of AIDS-related diseases in the first year of ART, and the cumulative survival rates at 10 and 18 years of ART were 78.3% and 71.8%, respectively. The proportion of the HIV/AIDS cases with baseline CD4T lymphocyte (CD4) counts <200 cells/μl at age 15 years when ART started was 45.5% (30 432/66 898). Cox proportional risk regression model showed that, compared with the cases with baseline CD4 counts ≥350 cells/μl, the risk of death was 1.78 times higher than in the cases with CD4 counts <200 cells/μl (95%: 1.64-1.94) and 1.24 times higher in the cases with CD4 counts ≥200 cells/μl (95%: 1.13-1.36), respectively. The risk of death in symptomatic cases at baseline survey was 1.25 times higher than that in asymptomatic cases (95%: 1.16-1.35). The cases with a latest viral load ≥1 000 copies/ml had 7.09 times higher risk of death than those with a last viral load<1 000 copies/ml (95%: 6.65-7.54). The majority of HIV/AIDS deaths occurred in the cases aged ≥15 years receiving ART in Henan province during 2002-2019, who were infected through blood-borne transmission and farmers/migrant workers, and AIDS-related diseases were the main causes of the deaths. With the gradual implementation of ART policy, the high survival rate in HIV/AIDS cases can be maintained for a long time in Henan. To reduce the case fatality rate and improve the quality of life of HIV/AIDS patients, CD4 counts test should be further strengthened and eligible HIV/AIDS patients should be covered by standard ART in a timely manner.

摘要

分析2002年至2019年河南省15岁及以上接受抗逆转录病毒治疗(ART)的艾滋病病毒/艾滋病(HIV/AIDS)病例的死亡率,为降低HIV/AIDS死亡率及艾滋病防治提供依据。从“传染病监测系统-艾滋病防治基本信息”中获取2002年至2019年在河南省接受ART的15岁及以上HIV/AIDS病例的数据。在这项回顾性研究中,采用Cox比例风险模型分析HIV/AIDS相关死亡的影响因素。使用SPSS 23.0软件进行统计分析。2002年至2019年,共有72986例15岁及以上的HIV/AIDS病例接受了ART,其中在此期间有16634例死亡。大多数死亡病例年龄≥40岁(68.5%,11393/16634),男性(62.6%,10419/16634),通过血液传播感染(71.7%,11927/16634),以及农民或农民工(91.7%,15249/16634)。大多数死亡是由于艾滋病相关疾病(73.7%,12261/16634),病死率为16.8%(12261/72986)。共有34.6%(4237/12261)的HIV/AIDS病例在ART的第一年死于艾滋病相关疾病,ART 10年和18年的累积生存率分别为78.3%和71.8%。开始ART时15岁时基线CD4T淋巴细胞(CD4)计数<200个细胞/μl的HIV/AIDS病例比例为45.5%(30432/66898)。Cox比例风险回归模型显示,与基线CD4计数≥350个细胞/μl的病例相比,CD4计数<200个细胞/μl的病例死亡风险高1.78倍(95%:1.64-1.94),CD4计数≥200个细胞/μl的病例死亡风险高1.24倍(95%:1.13-1.36)。基线调查时有症状病例的死亡风险比无症状病例高1.25倍(95%:1.16-1.35)。最新病毒载量≥1000拷贝/ml的病例死亡风险比最后病毒载量<1000拷贝/ml的病例高7.09倍(95%:6.65-7.54)。2002-2019年河南省大多数HIV/AIDS死亡发生在15岁及以上接受ART的病例中,这些病例通过血液传播感染且为农民/农民工,艾滋病相关疾病是主要死因。随着ART政策的逐步实施,河南省HIV/AIDS病例可长期维持较高生存率。为降低病死率并提高HIV/AIDS患者生活质量,应进一步加强CD4计数检测,及时为符合条件的HIV/AIDS患者提供规范ART。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验